Clinical Trial Update: A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study of GSK2894512 cream for plaque psoriasis completed. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• GSK2894512 cream (GSK2894512)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2017-11-13